CAR T Cell Therapy Market Emerging Trend, Opportunities, Key Players, Huge Growth, Revenue Analysis, 2023-2035 The latest report entitled ‘CAR T Cell Therapy Market’ by Roots Analysis provides an accurate estimation of the market size, regional landscape description, and revenue forecast over the projected timeframe. The current global CAR T-cell therapy market size is likely to be worth USD 4.6 billion, and is projected to reach worth USD 15.2 billion by 2035, growing at a CAGR of 11.4% during the period, till 2035. The report turns the spotlight on the major challenges faced by the key players in the global market and the growth strategies currently adopted by them. The report is a granular assessment of this particular business sphere and entirely covers the dynamic competitive landscape of the market. The document offers key insights into the market positions of these players alongside their gross earnings. Furthermore, it elaborates on each of the market segments, with detailed scrutiny of the development scope and competitive scenario of the regional fragments of the market. The latest study is inclusive of an in-depth analysis of the economic status of the CAR T Cell Therapy Market and examines the most important regions constituting the global market. It further details on the most lucrative and growth-oriented regions, top market rivals, diversified product types, and a large number of end-use industries. Key factors affecting the growth of the CAR T Cell Therapy Market: Geographical Overview: • The latest report broadly categorizes the CAR T Cell Therapy Market into several geographical terrains, including North America, Europe, Asia-Pacific, Latin America, Middle East and North Africa and Rest of the World. • The study is inclusive of essential information relevant to each region in this broad industry segment, along with the key drivers of the regional market growth. • The report further estimates the revenue accumulated by these regions over the forecast period. Competitive Hierarchy: • The latest research report studies the major market players, their regional presence, industry share, and production facilities. • The report offers significant data pertaining to these market competitors’ company profiles, product types, and application outlook. • Moreover, the pricing models and gross margins of these industry majors have also been mentioned in the report. Key players Autolus, Bluebird Bio, Bristol Myers Squibb, Carsgen Therapeutics, Cellectis, Gilead Sciences, Innovative Cellular Therapeutics, Noile-Immune Biotech, Novartis, Shanghai GeneChem, Sinobioway Cell Therapy, Takara Bio and Wellington Zhaotai Therapies. Additional parameters of the CAR T Cell Therapy Market report: • The latest research study endows the reader with a comprehensive analysis of the product types of the CAR T Cell Therapy Market, categorizing the relevant information into the Distribution by Target Inidcation, Target Antigens and Key Geographical Regions. The study focuses on the wide-ranging application landscape of the market, segmenting it into the market share, estimated growth rate, and the forecast product demand for each application type. Additional Insights: • The market concentration rate and processing rate of raw materials have also been conscripted in the report. • The report contains an assessment of the current price trends, as well as the factors influencing the global market size. • It throws light on the significant marketing strategies implemented by the eminent players in the industry. • Vital data and information concerning the producers, distributors, and downstream buyers involved in the global market, as well as the cost structure analysis and market mechanism, form the important elements of this report. Research objectives: • The CAR T Cell Therapy Market report studies the worldwide market consumption rate in terms of value and volume. • It identifies the various sub-segments of the market structure. • It proffers information regarding the leading global manufacturers in this industry, describing their market value & share, sales volume, competitive analysis, SWOT analysis, and development strategies adopted during the forecast timeline. • The report describes the key industry players, with respect to their individual growth trends, future prospects, and contribution to the global market, and explains the factors related to their market growth potential, drivers, opportunities, threats, and industry-specific challenges. • Furthermore, the report underpins the strategic developments occurring in the CAR T Cell Therapy Market, such as expansions, mergers & acquisitions, agreements, as well as new product launches. To view more details on this report, click on the link https://www.rootsanalysis.com/reports/car-t-cell-therapy-market/269.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. We specialise in analysing areas which have lacked quality research so far or require more focused understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way. The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organisations worldwide. Contact: Roots Analysis +1 (415) 800 3415 Sales@rootsanalysis.com

Cartilage Repair Market Global Latest Trends and Insights 2024 to 2031 Leading market research firm SkyQuest Technology Group recently released a study titled ‘Cartilage Repair Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024–2031,’ This study Cartilage Repair report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Cartilage Repair Market extensively demonstrates existing and upcoming opportunities, profitability, revenue growth rates, pricing, and scenarios for recent industry analysis. The research analysis on the global Cartilage Repair Market report 2024 offers a close watch on top industry rivals along with briefings on their company profiles, strategical surveys, micro as well as macro industry trends, futuristic scenarios, analysis of pricing structure, and an all-encompassing overview of the Cartilage Repair Market circumstances in the forecast period between 2024 and 2031. The global Cartilage Repair Market is a dynamic and rapidly evolving sector, encompassing the development, production, and distribution. This market is essential for improving global market and driving economic growth through innovation and industry advancements. Market Growth The Cartilage Repair Market has experienced robust growth over the past decade and is projected to continue expanding. Cartilage Repair Market size was valued at USD 927.63 million in 2022 and is poised to grow from USD 1040.29 million in 2023 to USD 1570.16 million by 2031, growing at a CAGR of 12.13% in the forecast period (2024–2031). This growth is driven by several factors, including an aging global population, increasing prevalence of advancements in technology, and rising global expenditure. Chance to get a free sample @ https://www.skyquestt.com/sample-request/cartilage-repair-market Detailed Segmentation and Classification of the report (Market Size and Forecast — 2031, Y-o-Y growth rate, and CAGR): The Cartilage Repair Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. Treatment modality type Cell-Based (Chondrocyte Transplantation, Growth Factor Technology), Non-Cell-Based (Tissue Scaffolds, Cell-Free Composites) Application Hyaline, Fibrocartilage Treatment type Palliative (Viscosupplementation, Debridement & Lavage), Intrinsic Repair Stimulus Site Knee Cartilage Repair (Arthroscopic Chondroplasty, Autologous Chondrocyte, Osteochondral Grafts Transplantation, Cell-based Cartilage Resurfacing, Microfracture, Other), Other Regional Analysis: On the basis of region, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The Cartilage Repair Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications. Get your customized report @ https://www.skyquestt.com/speak-with-analyst/cartilage-repair-market Following are the players analyzed in the report: DePuy Synthes (a subsidiary of Johnson & Johnson) Zimmer Biomet Holdings Inc. Smith & Nephew plc Vericel Corporation Osiris Therapeutics Inc. (acquired by Smith & Nephew in 2019) Histogenics Corporation Anika Therapeutics Inc. Arthrex Inc. B. Braun Melsungen AG Stryker Corporation CONMED Corporation Orthocell Limited RTI Surgical Holdings Inc. MEDIPOST Co. Ltd. CellGenix GmbH Tissue Regenix Group plc CollPlant Biotechnologies Ltd. ISTO Technologies Inc. MTF Biologics CartiHeal Ltd Regional Analysis 1. North America: - The United States and Canada dominate the North American Cartilage Repair Market. The U.S. is the largest market globally, driven by advanced global infrastructure, high R&D investments, and significant Cartilage Repair consumption. 2. Europe: - Europe is a significant player, with major Cartilage Repair Markets in Germany, France, and the United Kingdom. The region benefits from strong regulatory frameworks, high industry standards, and a robust R&D sector. 3. Asia-Pacific: - This region is experiencing rapid growth, with countries like China and India leading the charge. Factors such as increasing industry access, growing middle-class populations, and expanding Cartilage Repair manufacturing capabilities contribute to this growth. 4. Latin America: - Brazil and Mexico are key markets in Latin America. Growth in this region is driven by rising industry needs, increasing investments in industry infrastructure, and a growing demand for affordable medications. 5. Middle East and Africa: - The Cartilage Repair Market in this region is expanding due to rising market spending, increased prevalence of diseases, and improvements in Market infrastructure, although the market is relatively smaller compared to other regions. Future Outlook The Cartilage Repair Market is poised for continued growth driven by technological advancements, expanding global market access, and increasing global industry needs. As the industry adapts to evolving challenges and seizes emerging opportunities, it is likely to see ongoing innovation and expansion, contributing significantly to global health and economic development. Buy your full report: https://www.skyquestt.com/buy-now/cartilage-repair-market

Drug Screening Market: Competitive Insights and Precise Outlook | 2024-2031 Drug Screening Market Overview: A lot of factors, such as geographic growth, segmentation, and market size by value and volume, are taken into account in the SkyQuest Technology Group research to provide a full and accurate analysis of the global Drug Screening market. This outstanding research study was created specifically to provide the most latest data on significant aspects of the global Drug Screening Industry. Numerous market estimates are provided in the analysis, including those for market size, output, revenue, consumption, CAGR, gross margin, price, and other critical factors. The best primary and secondary research methods and tools on the Drug Screening market were used to build it. Numerous research studies are included in it, including ones on pricing analysis, production and consumption analysis, company profile, and manufacturing cost analysis. Global Drug Screening Market size was valued at USD 8.9 billion in 2022 and is poised to grow from USD 10.37 billion in 2023 to USD 35.18 billion by 2031, growing at a CAGR of 16.5% during the forecast period (2024-2031). The competitive environment is a crucial element that every key factor needs to be aware of. The study explains the market's competitive landscape so that readers may gauge the degree of both domestic and global rivalry. Additionally, market researchers have provided summaries of each significant firm in the global Drug Screening industry, taking into consideration crucial elements including operational areas, production, and product portfolio. When analyzing the organizations in the study, significant factors including business size, market share, market growth, revenue, production volume, and profitability are also taken into account. The study report uses both qualitative and quantitative data to offer a thorough view of the market. It examines and forecasts the global market in a number of critical industries. The research provides a thorough overview of the industry by segmenting the Drug Screening market into groups based on application, end-user, and location. A thorough research of each market segment was conducted, taking into consideration current and upcoming market trends. Chance to get a free sample @ https://www.skyquestt.com/sample-request/drug-screening-market Detailed Segmentation and Classification of the report (Market Size and Forecast - 2031, Y-o-Y growth rate, and CAGR): The Drug Screening Market can be segmented based on several factors, including product type, application, end-user, and distribution channel. Understanding these segments is crucial for companies looking to target specific markets and tailor their offerings to meet consumer needs. • Product & Service o Drug Screening Services [Laboratory Testing Services, On-site Testing Services], Drug Screening Products [Analytical Instruments (By Type {Breathalyzers “Fuel-cell Breathalyzers, Semiconductor Breathalyzers, Other Breathalyzers”, Immunoassay analyzers, Chromatography instruments}, By Modality {Hand-held drug screening products, Benchtop drug screening products}, Rapid Testing Devices (Urine testing devices {Drug testing cups, Dip cards, Drug testing cassettes}, Oral fluid testing devices), Consumables {Assay kit, Sample collection devices, Calibrators and controls, Other consumables}] • Sample Type o Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other Samples • Drug Type o Cannabis, Alcohol, Cocaine, Opioids, Amphetamine and Methamphetamine, Other Drugs • End User o Drug Testing Laboratories, Workplaces, Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, Other End Users Get your Customized report @ https://www.skyquestt.com/speak-with-analyst/drug-screening-market Following are the players analyzed in the report: • Quest Diagnostics (US) • Abbott (US) • OraSure Technologies Inc. (US) • Alfa Scientific Designs Inc. (US) • Thermo Fisher Scientific, Inc. (US) • Drägerwerk AG & Co. KGaA (Germany) • Lifeloc Technologies, Inc. (US) • MPD Inc. (US) • Omega Laboratories, Inc. (US) • Premier Biotech, Inc. (US) • Psychemedics Corporation (US) • F. Hoffmann-La Roche Ltd. (Switzerland) • Shimadzu Corporation (Japan) • Siemens Healthineers AG (Germany) • American Bio Medica Corporation (US) • ACM Global Laboratories (US) • CareHealth America Corp. (US) • Clinical Reference Laboratory, Inc. (US) • Intoximeters (US) • Sciteck, Inc. (US) • AccuSourceHR, Inc. (US) • Cordant Health Solutions (US) • Intoxalock (US) • Millennium Health (US) • AdvaCare Pharma (US) Motives for purchasing this report- - A full understanding of customer experiences, upcoming trends, and growth drivers may be obtained by market category analysis. -Drug Screening Market participants will be able to quickly decide on their course of action in order to achieve a competitive advantage thanks to the essential information provided in this area. The factors affecting the sales prospect are carefully examined by SkyQuest Technology Group across several important categories. - Analysing market categories can provide detailed insights into consumer experiences, upcoming trends, and growth-promoting factors. A thorough analysis of market manufacturing trends is a crucial component of the study. -These observations offer crucial information on the ways in which market participants are reacting to the most recent developments that are oversaturating the market. -An in-depth analysis of the numerous organic Buy your full Market Report now: https://www.skyquestt.com/buy-now/drug-screening-market FAQs: 1. What are the main vendors' points of strength and weakness? 2. What are the primary business plans of the leading important players for the near future? 3. What will the market size and growth rate be for Drug Screening in the upcoming year? 4. Which prevailing global trends are affecting the Drug Screening market shares of the leading regions? What effect does Covid19 have on the Industry right now?

EU: ARRIVA LA TESSERA VACCINALE A partire dal prossimo settembre cinque nazioni europee – Belgio, Germania, Grecia, Lettonia e Portogallo – sperimenteranno la nuova Tessera Vaccinale Europea (EVC). Tale certificato verrà sperimentato in diversi formati, dalla tessera vera e propria (tipo carta di credito) fino al formato digitale, da caricare direttamente nello smart phone. Secondo Vaccines Today https://www.vaccinestoday.eu/stories/european-vaccination-card-will-be-piloted-in-five-countries/ la nuova Tessera Vaccinale "mira a dare potere alle persone, consolidando tutti i loro dati vaccinali in un'unica posizione facilmente accessibile”, mentre il programma sperimentale “mira ad aprire la strada ad altri paesi, armonizzando la terminologia vaccinale, sviluppando una sintassi comune, garantendo adattabilità in diversi contesti sanitari e perfezionando i piani di implementazione dell'EVC". Il sito Children’s Health Defense di Robert Kennedy Jr. ha raccolto i commenti di diversi medici ed esperti del settore sulla tessera vaccinale europea: Il dott. David Bell, medico della sanità pubblica, consulente biotech ed ex direttore di Global Health Technologies, ha affermato: "La proposta di tessera vaccinale riflette un crescente sforzo di utilizzare gli strumenti della sanità pubblica come mezzo per concentrare la ricchezza e fornire un mezzo per controllare le popolazioni. Ricorda molto gli approcci in alcune parti d'Europa prima della seconda guerra mondiale, e serve essenzialmente ad uno scopo simile: escludere dalla società gli individui che non vogliono obbedire alle istruzioni del governo. La sperimentazione in Europa è il naturale passo successivo, che aumenta notevolmente la probabilità di lockdown ricorrenti per consentire la vaccinazione obbligatoria di massa, e quindi per aumentare i profitti sui vaccini". Anche l'avvocato olandese Meike Terhorst ha criticato il programma pilota, definendo il passaporto vaccinale digitale una "minaccia diretta alla nostra libertà e anche alla sovranità di qualsiasi stato. Tutti i nostri poteri sono affidati ai globalisti, al gruppo di banchieri e investitori". Catherine Austin Fitts, ex vice-ministro USA per l'edilizia e lo sviluppo urbano, ha affermato: "L'obiettivo è il controllo finanziario. Non esiste uno scopo legittimo di salute pubblica. I banchieri centrali si nascondono dietro una narrazione sanitaria: politiche come il lockdown sono un modo per gestire l'inflazione e la domanda di risorse quando la politica monetaria è altamente inflazionistica". Gli esperti hanno anche collegato l'implementazione dell'EVC agli avvertimenti del governo e dei funzionari sanitari sulla "prossima pandemia", potenzialmente causata dall'influenza aviaria o da una "Malattia X" ancora sconosciuta. Secondo Fitts "è in atto una strategia per prepararsi a una pandemia di influenza aviaria. I vaccini contro l'influenza aviaria sono già stati spediti in Europa. Una tessera vaccinale può essere utilizzata per cercare di fare pressione o costringere le persone a fare un'altra iniezione non necessaria". Meike Terhorst ha concluso: "Il passaporto vaccinale digitale è un mezzo tecnico per violare le libertà personali, come il diritto di dire di no a una vaccinazione. È un mezzo per trasformare esseri umani liberi in schiavi. Questo passaporto vaccinale digitale è stato pianificato molti anni in anticipo dai globalisti". Ma l’Europa della Von der Leyen se ne frega di queste opinioni. Loro – i burattini delle case farmaceutiche – vanno avanti come schiacciasassi lungo il loro percorso, stabilito e progettato già molti anni fa. Solo una presa di coscienza collettiva e una robusta ribellione da parte della popolazione europea potranno fermare la nostra caduta verso la definitiva schiavitù. Massimo Mazzucco PS: Se non riuscite a condividere questo post, fate copia-e-incolla.

https://dituttoedipiu.altervista.org/bill-gates-investe-molto-nella-tecnologia-mrna-i-contribuenti-lo-stanno-aiutando/ #BillGates #tecnologiamRNA #investimenti #BigPharma #ricerca #vaccini #biotecnologia #innovazione #scienza #medicina #Covid19 #pandemia #farmaceutica #salute #trasparenza #contribuenti #fondi #finanziamenti #biotech #saluteglobale #GatesFoundation #biologia #genetica #sviluppotecnologico #vaccinazione #efficacia #sicurezza #impatto #società #economia

In molti riportano questa intervista alla prof. Dolores Cahill, dell'Univ di Dublino biotech-atelier.com/speakers/prof-… un poco terrificante perchè aveva previsto che da 3 anni dalla vaccinazione, quindi ADESSO, i morti per vaxx si moltiplicheranno. La prof. Cahill è una scienziata e anche le riviste pro-vaxx nel 2021 ammettevano la sua importante statura scientifica, lavorava al Max Planck ed era consulente del governo. Se leggi questo articolo contro di lei, vedi che, per così dire, la temono come scienziata mcgill.ca/oss/article/co… Ad ogni modo, la riportano in tanti perchè spiegava che dal 3 al 5 anno dalla vaccinazione, molti vaccinati moriranno, cioè che la sostanza tossica non solo non si "diluisce" con il tempo, ma è dal terzo anno che farà più morti. E per la maggioranza, il terzo anno dalla vaccinazione è adesso... https://twitter.com/pbecchi/status/1742297298523074779?t=jofloFWb886oqSWlJAn0uw&s=19

http://www.msfbees.com/ Honey Centrifuge Free Sample Our History Henan mingshengfeng Biotechnology Co., Ltd. has developed from a small family beekeeping farm to a comprehensive group company with an annual output value of over 100 million RMB. Through the efforts of three generations: In 1958, grandfather Gary Guo called on his family to start the beekeeping business together. After 20 years of efforts, he developed into a small company with 50 employees and three beekeeping farms. Mainly engaged in the production and sales of bee products. In 1978, uncle Kevin Guo took over the company, and we ushered in a leap forward growth. During this period, we have built a large number of standardized beekeeping farms and expanded the preliminary production and sales scale of bee products. In addition, we have also built new production plants to increase the processing and sales of simple bee tools and equipment and bee products. Since 2009, under the leadership of Mr. Meng Guo, the third generation leader, we have upgraded and built a modern bee farm, introduced a variety of new production lines, so that we have the production and manufacturing capacity of a full range of bee tools and equipmeng , self-research and cooperation in the construction of bee product production line... All these efforts have made our product quality smoothly meet international standards. While further stabilizing our domestic market share, we have also successfully developed and rapidly expanded our international business. Our Factory Today, not only we have more than 200 bee farms, but build large-scale comprehensive warehouses (support long-term refrigerated and frozen storage), laboratories and seven major factories: wood products processing factory, plastic products factory, hardware processing factory, machinery and equipment manufacturing factory, protective clothing production factory, bee product processing factory and custom packaging factory. Our Product Our company mainly operates 2 categories and 1 series of products: Bee equipment: beehive, beekeeping tools, beekeeping machinery, beekeeping equipment, protective wearing. Bee products: Honey, beeswax, bee pollen, propolis, royal jelly Product Application Our products are numerous, among which bee appliances are mainly used for beekeeping. Bee products are mostly used in food and health products, daily cosmetic products, handicrafts and others, and some of them are used in the fields of aquaculture industry lubrication teaching tools. For specific application of a single product, please refer to the detailed introduction page of the corresponding product or consult our sales manager of the corresponding product. Our Certificate Since establishment, our company has strictly complied with laws and regulations, and has successively obtained the general certification of SGS field certification, ISO9001 quality system certification, GMP workshop certification and food production license. For specific products, please consult our corresponding product sales manager for the documents for your custom clearance and market access qualification for specific products such as: inspection report, product certification, design and patent authorization, etc. Production Equipment In order to maintain competitive prices and stable quality, it is necessary for us to introduce in the latest production equipment: Bee products production equipment: metal tank, vacuum machine, centrifuge, dehumidifier, dryer, and for other various purposes of dust remover filter, along with other mechanical equipment for specific products Bee equipment production equipment: wood cutting machine, slotting machine, other automatic finishing tools, wax boiling machine, painting equipment, plastic products production machinery, hardware products production machinery, honey machine production line, foundation sheet machine production line, polishing machine,. metal cutting machine, laser printer, etc Packaging machine: filling machine, plastic bag sealing machine, bottle sealing machine, printer, printing machine, automatic packaging machine Laboratory equipment: microscope refractometer, electro-thermal incubator, electric blast, constant temperature drying chamber, pressure sterilizer and analysis instruments for various specific products Please consult our product sales manager for the processing and production of specific products and the mechanical equipment involved. Production Market In more than half a century of working, we have always attached great importance to the common interests of upstream and downstream partners, and did not blindly expand in order to ensure quality of our products and delivery time. With this standard, we have steadily developed and gradually won more customers' trust and market share. Before 2009, domestic market contributed most of our sales, and the main products were bee appliances and bee products, and we were also laying out for international market shares. After 2009, international market has contributed more than half of our sales. Our products are sold to North America, Australia, Europe, Japan, South Korea, Central Asia and Southeast Asia and other countries and regions. Our products are directly or indirectly supply the head online and offline distributors of pharmaceutical factory and health products factory, and personal offline supermarket chain stores such as Amazon, eBay and others. In recent years, the quantity of small batch customization products in fine processing has grown most rapidly, and it has been welcomed by small and medium-sized enterprises. Our Service Since the establishment, our company has taken quality and service as the basis of our development. For a long time, we have established and improved a systematic service system by collecting the opinions and suggestions of customers and combining our own industry experience Before placing an order: bilingual sales manager will help you and try to meet customer needs (if there is any order, senior product consultant will join in for assistance); select the appropriate transportation mode (air, sea, railway transportation, some products may need frozen transportation) according to the product list; confirm the value and freight of goods After order: sales team submits the order information and delivery date to the supply chain team: there is inventory, and the goods are delivered after packaging; if there is no inventory, the factory is informed to deliver the goods after the completion of production Before receiving: customer checks the quantity of products, and checks whether the products are damaged, the quantity is correct. If there is no damage, then goods are confirmed. If there is any damage caused by transportation, please inform our bilingual sales manager. We will assist you in applying for compensation from the freight company and sending the corresponding products again. After receiving: bilingual sales manager provides online installation and application guidance, and applies for senior product consultant assistance for you when necessary.Honey Centrifuge Free Sample website:http://www.msfbees.com/

Most herbal and dietary supplements don’t lead to weight loss, a review of existing studies has found.Researchers looked into data for green tea extract, guar gum, and acupuncture, among many others.http://www.haiyubiotechnology.com/dietary-supplement/